Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through Jak1 and Stat3 in astrocytes

被引:99
作者
Justicia, C
Gabriel, C
Planas, AM
机构
[1] CSIC, Inst Invest Biomed Barcelona, Dept Farmacol & Toxicol, IDIBAPS, Barcelona 08036, Spain
[2] UB, Fac Farm, Dept Farmacol & Farmacognosia, Barcelona, Spain
关键词
rat; middle cerebral artery occlusion; stroke; signal transduction;
D O I
10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
JAK/STAT is one of the pathways bearing signals from the cell membrane to the nucleus in response to extracellular growth factors and cytokines. In the present study, we examined the cellular distribution of Jak1 and Stat3, and activation of the JAK/STAT pathway following transient focal cerebral ischemia in the rat. Jak1 was mainly seen in white matter astrocytes and in certain neurons. Notably, large pyramidal neurons of cortical layer V showed the highest neuronal Jak1 expression within cerebral cortex and, in addition, expressed Stat3 indicating that the JAK/STAT pathway is involved in signaling in the corticofugal projection system. Shortly following ischemia, Jak1 immunoreactive astrocytes located in the ipsilateral neighbouring white matter and ischemic cortex and striatum showed nuclear translocation of Stat3. These features were maintained in large reactive astrocytes that surrounded the infarct from 3 to 7 days. At these later times, the abundant reactive microglia/macrophages were strongly immunoreactive to Stat3 and, to a lesser extent, Jak1. Two main protein complexes showing DNA binding activity at the sis-inducible element site were found under basal conditions, followed by changes in this pattern following ischemia concomitant with neuronal cell loss and, activation of glia. This study showed basal cerebral activity of JAK/STAT signaling pathway, involving Jak1 and Stat3 proteins, and selective activation following ischemia. It is suggested that the kinase activity of Jak1 mediates nuclear translocation of Stat3 in astrocytes, and that this signaling pathway is involved in the astroglial response to focal cerebral ischemia. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:253 / 270
页数:18
相关论文
共 69 条
[1]
CYTOTOXICITY OF MICROGLIA [J].
BANATI, RB ;
GEHRMANN, J ;
SCHUBERT, P ;
KREUTZBERG, GW .
GLIA, 1993, 7 (01) :111-118
[2]
Tumor necrosis factor-alpha - A mediator of focal ischemic brain injury [J].
Barone, FC ;
Arvin, B ;
White, RF ;
Miller, A ;
Webb, CL ;
Willette, RN ;
Lysko, PG ;
Feuerstein, GZ .
STROKE, 1997, 28 (06) :1233-1244
[3]
Berhow MT, 1996, J NEUROSCI, V16, P8019
[4]
Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway [J].
Bonni, A ;
Sun, Y ;
NadalVicens, M ;
Bhatt, A ;
Frank, DA ;
Rozovsky, I ;
Stahl, N ;
Yancopoulos, GD ;
Greenberg, ME .
SCIENCE, 1997, 278 (5337) :477-483
[5]
PROTEIN-TYROSINE KINASE-DEPENDENT ACTIVATION OF STAT TRANSCRIPTION FACTORS IN INTERLEUKIN-2-STIMULATED OR INTERLEUKIN-4-STIMULATED T-LYMPHOCYTES [J].
BRUNN, GJ ;
FALLS, EL ;
NILSON, AE ;
ABRAHAM, RT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11628-11635
[6]
INDUCTION OF INTERLEUKIN-1-BETA MESSENGER-RNA AFTER FOCAL CEREBRAL-ISCHEMIA IN THE RAT [J].
BUTTINI, M ;
SAUTER, A ;
BODDEKE, HWGM .
MOLECULAR BRAIN RESEARCH, 1994, 23 (1-2) :126-134
[7]
Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat [J].
Buttini, M ;
Appel, K ;
Sauter, A ;
GebickeHaerter, PJ ;
Boddeke, HWGM .
NEUROSCIENCE, 1996, 71 (01) :1-16
[8]
Regulation of nociceptin orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes [J].
Buzas, B ;
Symes, AJ ;
Cox, BM .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) :1882-1889
[9]
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[10]
Cattaneo E, 1998, ANTICANCER RES, V18, P2381